NEW REPORT Americans will spend $137B on Keytruda during its extended monopoly
Through research, education, and partnerships,I-MAK is committed to finding solutions to address structural inequity in the medicines system.
See the latest in news from I-MAK experts
For press inquiries, please contact email@example.com
Partner with us now to build a more just and equitable medicine system for all.